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John Groffen1,4,5 and Nora Heisterkamp1,4,5*Abstract
Background: Acute lymphoblastic leukemia (ALL) cells treated with drugs can become drug-tolerant if co-cultured
with protective stromal mouse embryonic fibroblasts (MEFs).
Results: We performed transcriptional profiling on these stromal fibroblasts to investigate if they were
affected by the presence of drug-treated ALL cells. These mitotically inactivated MEFs showed few changes in
gene expression, but a family of sequences of which transcription is significantly increased was identified. A
sequence related to this family, which we named cassini, was selected for further characterization. We found
that cassini was highly upregulated in drug-treated ALL cells. Analysis of RNAs from different normal mouse
tissues showed that cassini expression is highest in spleen and thymus, and can be further enhanced in these
organs by exposure of mice to bacterial endotoxin. Heat shock, but not other types of stress, significantly
induced the transcription of this locus in ALL cells. Transient overexpression of cassini in human 293
embryonic kidney cells did not increase the cytotoxic or cytostatic effects of chemotherapeutic drugs but
provided some protection. Database searches revealed that sequences highly homologous to cassini are
present in rodents, apicomplexans, flatworms and primates, indicating that they are conserved in evolution.
Moreover, CASSINI RNA was induced in human ALL cells treated with vincristine. Surprisingly, cassini belongs
to the previously reported murine family of γ-satellite/major satellite DNA sequences, which were not known
to be present in other species.
Conclusions: Our results show that the transcription of at least one member of these sequences is regulated,
suggesting that this has a function in normal and transformed immune cells. Expression of these sequences
may protect cells when they are exposed to specific stress stimuli.
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The bone marrow microenvironment provides protection
to acute lymphoblastic leukemia (ALL) cells against drug
treatment and is a frequent site of leukemia relapse. Ex
vivo, primary pro-B ALL cells do not proliferate long-term* Correspondence: heisterk@hsc.usc.edu
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distribution, and reproduction in any mediumwithout the presence of stromal support [1]. We therefore
developed an ex vivo co-culture model consisting of
mouse leukemic pro-B lymphoblasts [2] grown with mito-
tically inactivated mouse embryonic fibroblasts (MEFs).
This system provides a generic type of protection to the
ALL cells as is evidenced by the emergence of drug resist-
ant ALL cells within 2-4 weeks of treatment with a moder-
ate dose of a therapeutic drug [3-8].
Some of the factors produced by stromal cells that pro-
vide protection to the ALL cells have been identified, and
include stromally produced SDF1α [4,9,10]. However, it isntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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the stromal fibroblasts. The current study was initiated to
examine this using expression profiling on the irradiated
MEFs. These experiments led to the identification of an
evolutionarily conserved family of multi-copy sequences,
of which transcription is increased in both the ALL cells
and the irradiated stromal cells when ALL cells are sub-
jected to drug treatment.
Results
Mitotically inactivated stromal cells upregulate expression
of a cluster of loci on chromosome 9 when exposed to
drug-treated ALL cells
To provide stromal support to ALL cells without problems
associated with the presence of two types of proliferating
cells, we standardly mitotically inactivate the stromal
MEFs by irradiation. Although these cells no longer divide,
they are able to provide support to the ALL cells under
steady-state growth conditions and also when the ALL
cells are challenged by therapeutic drug treatment.
The murine ALL cells used here express the Bcr/Abl
oncogene and are sensitive to the Abl tyrosine kinase in-
hibitor nilotinib. Previous experiments using different
concentrations of nilotinib showed that 16 nM of this
drug eradicates large numbers of 8093 ALL cells, but
allows cells to grow out that have become tolerant to
this concentration of drug [3].
When these ALL cells are co-cultured with protective
stromal cells, they adhere loosely to the top of this layer
and migrate underneath it. To be able to isolate a pure
population of protective MEFs, we therefore separated
the ALL cells from the irradiated MEFs using Transwell
membranes. Microarray analysis was performed on
RNA isolated from MEFs exposed to DMSO, to niloti-
nib, and to nilotinib plus ALL cells at the end of the
treatment on day 9 when the ALL cells had recovered
(Figure 1A, B). As expected, there were minimal differ-
ences in the transcriptomes between MEFs treated with
DMSO and nilotinib since this drug is a specific inhibi-
tor of the deregulated Bcr/Abl tyrosine kinase oncogene
in the lymphoblasts. Compared to DMSO-treated
MEFs, only 59 probesets reported larger than 2-fold
increased expression in MEFs exposed to nilotinib-
treated ALL cells. Of these, only 13 reported values that
exceeded a 3-fold upregulation.
Among those sets with highly increased expression, an
interesting profile was reported by 8 probesets repre-
senting three genes located on chromosome 9 band A1
and one on chromosome 2 in band E1 (Additional file 1:
Figure S1A, B). Expression was increased 3-10-fold in
MEFs that were in contact with nilotinib-treated ALL
cells (Additional file 1: Figure S1A). These probe sets
are not present on previous murine Affymetrix gene
expression arrays.Chromosome 9 cluster contains members of an
evolutionarily conserved family of sequences
The annotation provided for one of the probesets, Gm10718
(Additional file 1: Figure S1B), indicates that its deduced
amino acid sequence is similar to that of the hypothetical
Plasmodium protein XP_675578. This region on mouse
chromosome 9 contained 11 other loci with significant hom-
ology to the original 3 located on chromosome 9. Alignment
of the deduced amino acid sequences from computer-
generated transcripts of these loci revealed a family of highly
related sequences (Additional file 2: Figure S2).
Further database analysis showed the existence of numer-
ous physical homologous cDNAs (conceptual translation of
nine distinct cDNAs, see Additional file 3: Figure S3), which
are distinct from the cluster of sequences on the chromo-
some 9 locus. We conclude that the mouse genome must
contain a large family of homologous but distinct genes of
which at least nine are transcribed into RNA.
Homologous sequences were present on every mouse
chromosome with 2753 mouse blast hits on 7_04_2011
in Refseq_genomic, many in the wgs and in the EST
database (for example in murine HSC, Cd11c + den-
dritic cells, unfertilized eggs, mesenchymal stem cells,
osteoblasts, lacrimal gland). Moreover, these sequences
are highly conserved in evolution. The malaria parasite
Plasmodium also contains numerous sequences, in
addition to the one represented by XP_675578, with a
high degree of similarity to this family. In the non-
human, non-mouse ESTs database, sequences from
Danio rerio, Pythium ultimum and Amphioxus Bran-
chiostoma were found. Also, Culex quinquefasciatus
contains a conserved hypothetical protein with high
homology (ED538491.1; www.ebi.ac.uk/ena/). Human
ESTs include for example AX647823, AW262283,
AW262311, AW262398, BI764521 and BG272890. Simi-
lar sequences were also detected in other species, such
as the lancelet Amphioxus Branchiostoma, a primitive
“living fossil” vertebrate, in the est_others database.
Cassini expression is high in hematopoietic cell types and
is upregulated by bacterial endotoxin in vitro and in vivo
Because we could not verify the existence of cDNAs that
matched the exact sequence of any members of the
chromosome 9 cluster, we obtained a cDNA, AK089719, of
which the deduced amino acid sequence was most homolo-
gous to the Plasmodium XP_675578 product (Additional
file 3: Figure S3 and Additional file 4: Figure S4) to further
investigate this family of genes. We named this specific
gene product cassini. The cDNA was generated from RNA
isolated from a murine activated spleen cDNA library. Pri-
mers for RT/PCR (indicated in the cDNA sequence in
Additional file 4: Figure S4A) amplified a single product of
the expected size (Figure 2A). We next subcloned the
cDNA insert into an EGFP-expression vector, transfected
Figure 1 Cassini expression in MEFs in response to DMSO,
nilotinib, or 8093 resistance to nilotinib. (A) Viability of 8093 ALL
cells over the course of a 9-day drug treatment with 16 nM nilotinib.
MEFs were physically separated from the ALL cells by a Transwell. At
day 9 (arrow), RNA was isolated from MEFs for gene expression
profiling. Viability is expressed as total number of viable cells/total
cell number. (B) Schematic indicating treatment of MEFs isolated for
gene expression profiling. Left, irradiated MEFs were treated with
DMSO or 16 nM nilotinib for 9 days. Right, irradiated MEFs were
separated from 8093 ALL cells by a Transwell membrane. The co-
cultures were treated with DMSO or 16 nM nilotinib for 9 days. (C)
Confirmation of cassini expression using real-time RT/PCR on RNA
isolated from MEFs. M, MEFs; D, DMSO; n, nilotinib (n = 3). Individual
values for biological triplicates of samples M + D, M + n and M +
ALL + n are indicated. Values are represented as mean ± SD of
duplicate real-time RT/PCR. *p < 0.05 nil + ALL versus DMSO + ALL.
(D) Cassini expression in MEFs treated with DMSO or 16 nM nilotinib,
alone, or separated from overlying ALL cells by a Transwell
membrane on the indicated days of drug treatment with 16 nM
nilotinib or with DMSO (n = 1). *p < 0.05 d6 and d10 MEFs exposed
to ALL/DMSO compared to MEFs exposed to ALL/nilotinib.
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cassini RNA using real-time RT/PCR. As shown in
Figure 2B, we detected high levels of the transcript in MEFs
transfected with the cDNA compared to non-transfected
cells or control cells transfected with EGFP. Dissociation
curves of the product generated with this primer pair in
real-time RT/PCR also support the amplification of a single
product (Figure 2C, D).
Since AK089719 was isolated from hematopoietic tissue
that had been activated, we first investigated cassini expres-
sion in mice exposed to bacterial endotoxin. As shown in
Figure 3A, the highest levels of cassini RNA were presentin the spleen and in the thymus of control mice. E. coli
endotoxin treatment of the mice further induced the tran-
scription of this locus 10-fold both in the thymus and
spleen (Figure 3B). Transcription was also increased in iso-
lated splenocytes stimulated ex vivo with LPS (Figure 3C).
Acute lymphoblastic leukemia cells increase cassini
transcript levels when exposed to therapeutic drugs
We next examined expression of cassini RNA in the MEF
samples used for the gene expression profiling. These
samples contain only MEF RNA since the fibroblasts were
physically separated from the ALL cells by a membrane
(Figure 1B). We found that nilotinib treatment of MEFs
had little effect on cassini expression, whereas the pres-
ence of ALL cells treated with nilotinib induced a 2-fold
increase (Figure 1C). To confirm that the presence of
nilotinib-treated ALL cells specifically induced cassini in
the MEFs, we isolated MEF samples on d2, d6 and d10 of
nilotinib treatment. As shown in Figure 1D, there was a
significant increase in expression of cassini in MEFs
exposed to drug-treated leukemia cells compared to MEFs
kept in the presence of DMSO-treated ALL cells.
To examine if ALL cells express cassini and whether
or not drug treatment affects this, we isolated RNA from
ALL cells treated with 16 nM nilotinib over the course
of 10 days. After an initial drop in viability, this typically
results in increased viability of the culture and emer-
gence of ALL cells that are able to proliferate at that
concentration of drug (Figure 4A, B). Figure 4C shows
that levels of cassini were comparable to the 0 hr control
at time points when viability of the ALL cells was still
high. However, decreased viability correlated with induc-
tion of cassini, of which expression increased 5-15 fold.
The peak of expression on day 4 correlated with the
Figure 2 Primer integrity and specificity analysis. (A) 2% agarose gel electrophoresis of control 8093 RT/PCR products using gapdh, 18 s rRNA,
and cassini shows a single band for each target gene. (B) Real time RT/PCR on RNA isolated from non-transfected MEFs (control), MEFs
transfected with an EGFP-cassini construct or with empty EGFP-C1 plasmid. Values (mean ± SD of triplicate real-time PCR) are expressed as
percent of gapdh. (C, D) Derivative dissociation curves from real-time RT/PCR on mouse (C) and human (D) RNA confirm single product
amplification. The cassini amplicon shows a single peak for both murine and human RNA with a Tm of ~76°C. Gapdh primers peak at Tm ~85.5°C.
***p < 0.001 EGFP-cassini compared to EGFP-C1 and control.
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cover. This suggests that cassini expression is related to
a stress response of the ALL cells.
The combined treatment of the ALL cells with niloti-
nib and aspirin delays the emergence of drug-resistance
(manuscript in preparation). To investigate the effect of
this treatment on cassini expression, we treated mouse
ALL cells co-cultured with irradiated MEFs with acetyl-
salicylic acid (ASA, aspirin), with nilotinib, and a com-
bination of the two. As shown in Figure 4D, aspirin
alone induced a modest upregulation of cassini. Interest-
ingly, the dual treatment with nilotinib and aspirin
caused a very high increase in cassini transcripts.
We additionally investigated if the mouse cassini pri-
mer pair would amplify a product in human RNA. Real-
time RT/PCR on RNA isolated from control and
vincristine-treated human ALL cells (Figure 4E) showed
that human CASSINI RNA was present in these cellsFigure 3 Real time RT/PCR of whole organ cassini expression in contr
tissues and 5 hrs after I.P. injection with 15 mg/kg E. coli LPS. Expression w
Triplicate real-time values are represented as percent of gapdh. *p < 0.05 LP
compared to control thymus. (C) Real time RT/PCR on RNA from control an
(n = 1).and that its expression was further increased by cyto-
toxic drug treatment. We also detected CASSINI RNA
in TXL2R cells that had been made tolerant to 500 nM
nilotinib (unpublished). Culture of these cells without
drug for 14 days, followed by de novo treatment with
nilotinib also induced a low increase in expression
(Figure 4F). These results further confirm that cassini is
evolutionarily conserved.
Induction of cassini by specific stress
To further investigate if cassini upregulation in ALL
cells correlates with cellular stress, we subjected 8093
pro-B leukemia cells to different types of treatments
including temperature change, hypertonic and hypotonic
stress, superoxide (H2O2) treatment and γ-irradiation.
Hypertonic shock did not affect levels of cassini, and
hypotonic treatment similarly had little effect (Figure
5A, B). Short-term radiation induced a non-significantol and LPS injected mice. (A, B) Cassini expression in different murine
as verified twice in sets of control and LPS-treated mice (n = 2).
S spleen compared to control spleen. ***p < 0.001 LPS thymus
d LPS (1 μg/mL) treated splenocytes isolated from a control mouse
Figure 4 Real time RT/PCR expression of cassini in pro-B ALL cells treated with therapeutic drugs in the presence of direct stromal
support. (A) Schematic representing the nature of a co-culture system in which ALL cells and stromal cells are in direct contact with one
another. Due to partial infiltration of ALL cells underneath the stromal layer, only ALL cells in the supernatant were harvested for RNA isolation
and gene expression purposes. (B) Viability of murine 8093 ALL cells over the course of drug treatment in the presence of MEFs. (C) Real time RT/
PCR analysis of cassini expression in 8093 ALL cells at indicated time points during drug treatment (n = 3). **p < 0.01 d1-d10 compared to 0 hr.
(D) 8093 cells treated with ASA, nilotinib or nilotinib + ASA (n = 2). ASA + nilotinib on d2, d8 and d12 versus nilotinib on d2, d8 and d12
*p < 0.05, **p < 0.01 and *p < 0.05, respectively. (E, F) Expression of CASSINI in human ALL cells in direct co-culture with irradiated OP9 stromal
cells (n = 1 each) and treated with (E) 2.5 nM vincristine over the course of 20 days, with US7 cells harvested at indicated time points, day 9 and
day 20 or (F) TXL2R cells cultured for 24 days without nilotinib (control), or cultured for 14 days without nilotinib, then treated with 500 nM
nilotinib for 10 days. Values are represented as mean ± SD of duplicate real-time RT/PCR. ***p < 0.001 US7 d20 vincristine compared to DMSO;
p = 0.06 (ns) TXLR control compared to TXLR2 d10 nilotinib.
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H2O2 did not significantly alter its expression (Figure 5E).
However, exposure of cells to elevated temperature did in-
duce a significant increase (Figure 5D).
Discussion
Mouse γ-satellite is not homologous to human γ-satellite,
but human-mouse homologous sequences exist
Overall, absolute levels of cassini in cells and tissues that
expressed it varied significantly, but were very high as
compared to that of the reference gene gapdh or 18 srRNA, and in some samples exceeded those of the
housekeeping transcripts. Therefore, it was remarkable
that this family had not been characterized. Further
database searches revealed that cassini and sequences
related to it belong to a class of DNA that has been col-
lectively named γ-satellite DNA in the murine genome.
Satellite DNA was named as such due to its buoyant
density on CsCl gradients, differentiating it from that of
the bulk of eukaryotic DNA. This is a consequence of its
different overall base pair composition. When we evalu-
ated the first DNA sequence reported for a mouse major
Figure 5 Real time RT/PCR expression of cassini in response to cellular stress. 8093 ALL cells were treated, as indicated in Methods, with (A)
hypertonic medium (n = 1); (B) hypotonic medium (n = 3); (C) radiation (n = 2); (D) heat shock (n = 3); and (E) H2O2 (n = 3). Values are
represented as mean ± SD of duplicate real-time RT/PCR. D **p < 0.01 heat shock versus control. Other comparisons, n.s., p > 0.05.
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sequence [11]. Vissel and Choo [12] coined the term γ-
satellite DNA for these sequences to distinguish this
mouse satellite DNA from other satellite families, such
as the mouse “minor” satellite, the human centromeric
N satellite and a new p-satellite family. However, the
term γ-satellite, as proposed by Vissel and Choo,
remains confusing in that it suggests relatedness be-
tween such sequences from different species. Mouse γ-
satellites were regarded as non-conserved in evolution,
and indeed we found that the sequences described as
human γ-satellite DNA repeats bear no sequence hom-
ology to the mouse γ-satellite DNA (not shown). In
addition, mouse γ-satellite DNA is reported to be peri-
centromeric, but we were unable to detect any homology
between the cassini-type sequences and the different
human pericentromeric repeats reported in Eymery et al.
[13]. We did find numerous human cassini-like EST
sequences and two non-assigned human genomic clones
from chromosome 7 and 18. However, in contrast to
mouse, none of these sequences have been assigned to a
chromosomal sublocation and therefore it is unknown
whether the human CASSINI loci are pericentromeric.
Similar to some classes of human pericentromeric
repetitive DNA, cassini mouse γ-satellite is
transcriptionally regulated
Interestingly, as reviewed in Ugarkovic [14], some of the
other satellite DNAs are also highly conserved. To theextent that the conservation of a sequence in evolution,
such as that of an exon versus an intron, signifies an
evolutionary constraint on divergence because of loss of
function, this would imply that sequences such as cassini
have a function. Vourc’h and Biamonti [15] reviewed
possible functions of satellite DNA, in particular human
pericentromeric satellite DNA, which has been more ex-
tensively studied. Although the human pericentromeric
satellites show no homology to the mouse γ-satellite
DNA, those located in the human 9q12 region show
increased expression in HeLa cells that are heat shocked
or stressed. Our results show that cassini expression is
regulated by heat shock suggesting that the human peri-
centromeric satellites and cassini share inducibility.
Mouse γ-satellite could be part of one large
transcriptional unit
Vissel and Choo [12] described the basic repeating unit
of the mouse γ-satellite DNA to be 234 bp, and the ma-
jority of monomers were reported to be organized into
largely uninterrupted arrays that vary from a minimum
of 240 kb to greater than 2000 kb in length. However, an
inspection of the only segment of the mouse genome
wherein the organization of the γ-satellite is precisely
reported shows that the 234 bp sequences are in fact
organized as exons within typical genes. The chromo-
some 9 cluster contains 12 blocks of these sequences
(Additional file 1: Figure S1A), organized in a tandem
head-to-tail configuration in the same transcriptional
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exon structure, with the γ-satellite sequences inter-
spersed by non-γ-satellite DNA sequences. In fact, the
automated DNA analysis software has annotated this
region as containing genes.
It is currently unclear whether this area would be tran-
scribed as 12 units or whether some of the units could
be spliced together to form a larger transcript. Murine
cDNAs corresponding in size to the predicted tran-
scripts of these units are listed in the databases. The
only indication that a very large spliced transcript could
exist is the fact that the Plasmodium genome also con-
tains homologous sequences, organized in a typical
exon-intron structure; the largest virtual cDNA that was
generated by automated annotation would be composed
of 26 exons containing multiple “γ-satellite” units.
Cassini shows some of the features of a typical gene
Whereas in earlier years repetitive DNA, including γ-
satellite DNA, was regarded as functionless, in the
course of twenty years, views on mouse γ-satellite DNA
appear to have evolved [14]. One paper reported detect-
ing a transcript in senescent cardiac muscle [16], and a
different study linked mouse γ-satellite transcription to
the cell cycle [17] suggesting that some of these
sequences may be transcribed.
Our current study, using real time RT/PCR, is the first
to extensively analyze and quantify transcription of one
such sequence, which we have named after the celestial
satellite cassini. The primer pair that we selected detects
a single product in the databases, and the melting curves
obtained from both mouse and human samples indicate
the primers amplify a single product. However, we can-
not definitively exclude the possibility that we are detect-
ing transcripts from more than one locus because
we presume that not all of these sequences are reported
in the databases. Nonetheless, individual γ-satellite
sequences that are reported as physical cDNAs have dis-
tinct nucleotide sequences. Thus, they represent distinct
loci, and the cassini primers detect transcription from
only a subset of these loci.
Furthermore, the detection of large differences in basal
and induced transcription of cassini in different mouse
tissues supports the specificity of its expression. If the
cassini transcript is the product from a single gene, then
specific stimuli, including endotoxin exposure and drug
treatment of pro-B ALL cells, induce extremely high
levels of this specific RNA. Our experiments standar-
dized cassini levels to those of the abundant gapdh and,
in some experiments, levels were measured that vastly
exceeded those of gapdh. Because the highest basal
levels of cassini were detected in thymus and spleen, its
expression may be regulated in hematopoietic cell types,
and we speculate that this could be promoted throughtranscription factors that were reported to bind mouse
γ-satellite DNA including Ikaros, a B-lineage specific
transcription factor that regulates the early development
of hematopoiesis [18], Glfi1b, which is an important
regulator of hematopoiesis [19-22] or YinYang1, which
is needed for differentiation of proB to preB cells [23].
Cassini protein?
It is currently unclear if cassini or other mouse γ-
satellite RNA is translated into a protein (see Additional
file 5: Figure S5 and Additional file 6) as we were unable
to demonstrate the existence of a protein that corre-
sponds in expression pattern to that of the cassini RNA.
Although our data clearly show that a Cassini protein
can be made, the product, if it exists, is likely to have
unusual characteristics as is demonstrated by the migra-
tion abnormalities and aggregation of EGFP-Cassini after
heat treatment in SDS-SB lysates (Additional file 5:
Figure S5).
Effect of cassini expression
Our experiments showed that induction of cassini RNA
in cells correlates with specific stress stimuli, but our
data do not provide information on whether the
increased levels are detrimental to the cells or contribute
a survival advantage. Because of the abundance of this
RNA upon stress of cells, and the possibility that other
transcribed loci exist in the genome with identical se-
quence, ablation of the RNA using siRNA does not ap-
pear technically feasible. We therefore used transient
transfection in 293 cells to attempt to achieve expression
levels that would significantly add to that already
induced endogenously by stress, and also subjected the
cells to a short-term treatment with chemotherapeutic
drugs. The results of these experiments rule out the pos-
sibility that cassini induction correlates with or contri-
butes to cell death, and suggest that high levels of this
RNA provide some form of protection against the cyto-
static activity of such drugs (Additional file 7: Figure S6).
Conclusions
We conclude that γ-satellite repeat sequences are widely
conserved and, as shown here, their transcription can be
specifically regulated. Our analysis of cassini demon-
strates that among this large family of loci, some are
likely to participate in the response of acute lympho-
blastic leukemia cells to cytotoxic drug treatment in can-
cer therapy in the presence of stromal support, and that
this may provide some protection against these drugs.
Methods
Data access
The microarray data have been deposited in GEO under
accession number GSE33329.
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8093 cells, a murine pro–B ALL cell line that was
isolated from a BCR/ABL transgenic mouse, human Ph-
negative US7 and Ph-positive TXL2 cells have been pre-
viously described in detail [3,24]. Briefly, 8093 cells were
cultured in McCoy’s 5A medium (Invitrogen) supple-
mented with 15% fetal bovine serum (FBS), 1% Gluta-
max, HEPES, 0.1% beta-mercaptoethanol, 1% penicillin/
streptomycin, and 0.01 ng/mL of IL-3. US7 and TXL2R
were cultured in αMEM (Invitrogen) supplemented with
20% FBS, 1% Glutamax, and 1% penicillin/streptomycin.
TXL2R cells were derived from TXL2 by prolonged cul-
ture in the presence of nilotinib. Cells are able to prolif-
erate normally in the presence of 500 nM of the drug.
Primary total mouse splenocytes were incubated for
5 hrs in RPMI (Invitrogen) supplemented with 10% FBS,
1% Glutamax and 1 μg/mL of E. coli endotoxin or
1xPBS. For drug treatment experiments, murine and
human ALL cells were co-cultured, directly or indirectly,
in the presence of mitotically inactivated stromal MEF
or OP9 feeder layers, respectively. For collection of
leukemic cells in Figures 4 and 5A, a direct co-culture
was used that results in cell-cell contact. Although ALL
cells migrate underneath the stromal layer, they also pro-
liferate abundantly in the supernatant. Because the MEFs
are fully adhered to the plates, a pure population of
leukemic cells is available for isolation (see schematic
Figure 4A). In indirect co-cuture, leukemic cells are
cultured in Transwells with 0.4 μM pore size, which pre-
cludes cell migration, but allows for free exchange of co-
culture media. The Transwells are placed over the MEF
stromal layer, allowing for a clean isolation of the MEFs
(see schematic Figure 1B). Drugs including nilotinib,
vincristine, and/or ASA, were refreshed every 48 hrs.
Atttainment of resistance was measured by viability
changes over the course of the experiments. Viability
was assessed using Trypan blue exclusion. The cellular
stress treatments (Figure 5) were performed in the ab-
sence of stroma, as they were short-term and therefore
did not necessitate MEF support. Heat stress was applied
for 30 minutes at 42°C in a water bath, with control cells
maintained at 37°C under the same conditions. Cell via-
bility in these experiments using Trypan blue exclusion
was determined to be higher than 90%. ROS stress was
induced by treating cells with the indicated concentra-
tions of H2O2 for 3 hrs at 37°C. γ-irradiation was carried
out on cells in suspension using a Gammacell 1000
(Nordion International, Inc). Cells were irradiated for
the indicated duration at a dose rate of 2341 rads/4 min,
followed by a 1 hr recovery at 37°C. Hyper-osmotic
stress was generated by supplementing the McCoy’s 5A
culture medium with 25–500 mM sorbitol. Cells were
treated for 24 hrs at 37°C. Hypo-osmotic stress condi-
tions were generated by diluting McCoy’s 5A mediumwith sterile, de-ionized water. Cells were incubated in
the indicated dilutions for 1 hr at 37°C. Experiments
involving transfection of EGFP-cassini into COS-1 and
293 FT HEK cells are described in more detail in
Additional file 6.
RNA purification from tissue and cells
All animal experiments were carried out in accordance
with Institutional IACUC and NIH guidelines. For tissue
expression analysis, mice were injected I.P. with 15 mg/
kg E. coli LPS or saline. 5 hrs later, animals were sacri-
ficed and tissue samples were harvested and stabilized in
RNAlater (Qiagen) in preparation for RNA isolation
using an RNeasy Plus Mini Kit and its specific protocol
for RNA extraction from animal tissue. In addition to
treatment with a gDNA removal column that is included
in the kit, an on-column RNase-Free DNase (Qiagen)
treatment was incorporated in the protocol to ensure
complete removal of DNA. For in vitro experiments,
cells were harvested and re-suspended in RNAprotect
(Qiagen), and RNA was isolated as mentioned above.
After assessment of quantity and quality of RNA using
NanoDrop1000, purified RNA was reverse transcribed to
cDNA using a High Capacity 1st Strand Synthesis kit
(Applied Biosystems) in preparation for real time RT-
PCR analysis.
Real-time RT/PCR
Candidate primers in AK089719, which is 100%
homologous to AK171984, were identified using NCBI
Primer-BLAST and further analyzed for specificity using
OligoCalc (www.basic.northwestern.edu/biotools/oligo-
calc.html) and IDT (www.idtdna.com/analyzer/Applica-
tions/OligoAnalyzer/Default.aspx). The selected primer
pair did not yield any non-specific products and there
were no homologous sequences in the RefSeqQ RNA
database. No sequences in the Genome (all assemblies)
and nr databases with 100% homology were found on
02/10/09. To further confirm primer specificity, PCR
products were subjected to a melting curve analysis and
2% agarose gel electrophoresis analysis.
Primers for cassini target nts 882–905 (Upstream
5’-TGGCGAGGAAACCTGAAATGGTGG-3’) and 955–
932 (Downstream 5’-TCGGTTTTCTTGCCGTATTCCA
CG-3’) of AK_089719 result in a 74-bp product. Murine
glyceraldehyde 3-phosphate dehydrogenase was ampli-
fied using MgapdhU (5'-ACCCAGAAGACTGTGGAT
GG-3') and MgapdhD (5'-CACCACACACTTGATGGC
CTGCAT-3'), which yielded a product of 171 bp. Murine
18 s rRNA was amplified using M18srRNAU (5’-GTGA
CTCTAGATAACCTCGG-3’) and M18srRNAD (5’-ACC
ATCGAAAGTTGATAGGG-3’), which yielded a product
of 87 bp. Human glyceraldehyde 3-phosphate dehydro-
genase was amplified using HGAPDHU (5’-CATTTCCT
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CTTCCTCTTGTG-3’), which yielded a product of 128 bp.
Real-time RT/PCR was performed as described in Behan
et al. [25]. Briefly, reactions were carried out using 25 ng
of cDNA, Power SYBR Green PCR Master Mix (Applied
Biosystems), and 200 nmol/L primers in an ABI 7900HT
Sequence Detection System (Perkin-Elmer, CA). Cassini
transcript levels were normalized to gapdh or 18 s rRNA
and the SD determined from duplicate or triplicate wells.
Gene expression profiling
Wild type MEFs were isolated using standard procedures.
MEFs were plated on 3x 10-cm dishes to generate bio-
logical triplicate samples. When cultured with 8093 Bcr/
Abl-positive ALL cells from a transgenic mouse model,
they were separated by Transwell membranes (75 mm
0.4 μM pores). 8093 cells above the MEFs were treated
with 16 nM nilotinib (n = 3). Two samples of MEFs co-
cultured with ALL cells treated with DMSO were found
to be contaminated by ALL cells and therefore a single
value of ALL + DMSO-treated MEFs was used. MEFs
were harvested on day 9. Control MEFs (n = 3) were trea-
ted with DMSO diluted 1:1000 or with nilotinib. RNA
was isolated using TRIzol according to the manufac-
turer’s (Invitrogen Corporation, Carlsbad, USA) instruc-
tions. Microarray hybridization was performed by the
University of Southern California Affymetrix MicroArray
Core Facility at Children's Hospital Los Angeles. Briefly,
RNA quality was first assessed using an Agilent Bioanaly-
zer (Agilent Technologies, Palo Alto, California, USA)
and the 28S/18S ratios of all of the samples were between
1.3 and 2. RNA was converted to cDNA with Superscript
Choice for cDNA Synthesis (Invitrogen, Carlsbad,
California, USA) and subsequently converted to biotiny-
lated cRNA with an Enzo High Yield RNATranscript label-
ing kit (Enzo Diagnostics, Farmingdale, New York, USA).
After hybridization to the murine Mouse Gene 1.0 ST
arrays (28,000 transcripts, Affymetrix, Santa Clara,
California, USA), the gene chips were automatically washed
and stained with streptavidin-phycoerythrin using a fluidics
system. The chips were scanned with a Hewlett-Packard
GeneArray Scanner (Hewlett-Packard, Palo Alto, California,
USA). Results were analyzed using Partek and Ingenuity
Systems (version 7.1) software programs. Average micro-
array values from individual time points were calculated
and log transformed.
Database searches
Additional file 6 provides supplementary details on the
database searches. In brief, to facilitate detection of hom-
ologous sequences, we translated the cDNA sequence of
AK089719 into protein using ReBaseTools (http://rebase.
neb.com/rebase/) and then used its deduced amino acid
sequence and that of XP_675578 and tblastn 2.2.21 and2.2.25+ against htgs, nr, est, and est_others with the low
complexity filter turned off.Additional files
Additional file 1: Figure S1. A cluster of genes near the telomere of
mouse chromosome 9. Graphic respesentation of Affymetrix microarray
results and table describing 40 kb region on mouse chromosome 9 band
A1.
Additional file 2: Figure S2. Deduced amino acid sequences of the
cluster of Genbank-designated genes on mouse chromosome 9.
Alignment of deduced amino acid sequences of chromosome 9 cluster.
Additional file 3: Figure S3. Translation of different physical mouse
cDNAs including AK089719 (cassini) with substantial homology to the
mouse chromosome 9 cluster. The deduced amino acid sequence of
mouse cDNAs are aligned.
Additional file 4: Figure S4. Cassini protein. Translation of cassini
cDNA, recurring amino acid motifs, and predicted secondary structure
showing putative transmembrane regions.
Additional file 5: Figure S5. Protein product of EGFP-tagged cassini
cDNA. Detection of EGFP-tagged Cassini protein in transfected COS-1
cells using polyclonal antisera and EGFP fluorescence.
Additional file 6: Description of data, methods and references for
Figures S1-S6. Contains a description of the results shown in Figures
S1-S6, the methods that were used to generate those data, and
references relevant to this information.
Additional file 7: Figure S6. Effect of cassini on survival of drug-treated
cells. 293 HEK cells were transfected with control pEGFP-C1 or pEGFP-
cassini and compared for viability and cell numbers after treatment for
24 hours with the chemotherapeutic drugs cisplatin, etoposide and
doxorubicin.
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